November 2022 FDA Recall Drug by Accord Healthcare, Inc.
D-0131-2023 - Labeling mixup

This Class I drug recall was voluntarily initiated by Accord Healthcare, Inc. on November 29, 2022 for the product Drug. The FDA reported the reason for recall as labeling mixup. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0131-2023

Reason for Recall
Labeling mixup: cartons labeled as Daptomycin 350 mg/vial were found to contain vials of Daptomycin 500 mg per vial
Initiated
11-29-2022
Reported
01-25-2023
Quantity
Unknown

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Accord Healthcare, Inc.
Nationwide within the United States
Daptomycin for Injection 350 mg/vial 1 Single-dose vial, Rx only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703 Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, India. NDC 16729-0434-05

Batch or Lot Expiration Information

Lot# Lot: R2200232 Exp. 01/2025